When investors are looking for fresh investment ideas, recent recommendations from Wall Street analysts can underscore compelling investment opportunities. This is where RBC Capital comes in. The investment firm has issued recommendations on 3 stocks, highlighting each based on its strong long-term growth prospects. While the firm’s analysts believe they are poised to surge at least 50% in the year ahead, we wanted to get the rest of the Street’s opinion. After using TipRanks’ database, we learned that each ticker has scored Buy ratings from other members of the analyst community as well. Verrica Pharmaceuticals (VRCA) We’ll start with Verrica Pharma, a therapeutics company working on treatments for dermatological conditions.
https://www.tipranks.com/news/article/rbc-capital-3-stocks-to-buy-with-over-50-upside-potential
Verrica Parmaceuticals (NASDAQ:VRCA)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more Verrica Parmaceuticals Charts.
Verrica Parmaceuticals (NASDAQ:VRCA)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more Verrica Parmaceuticals Charts.